Вход на сайт

Просмотр новости

Найдите то, что Вас интересует

Contrasting IMAC (IMAC) and Its Peers

Дата публикации: 10-08-2026 13:28:48

Profitability This table compares IMAC and its rivals’ net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets IMAC -75.40% -52.17% -34.51% IMAC Competitors -5.53% -138.28% -0.40% Valuation and Earnings This table compares IMAC and its rivals revenue, earnings per share (EPS) and valuation. Gross Revenue Net Income […]

Основное содержимое страницы с новостью.

Posted by Tristan Rich on Aug 10th, 2026

Profitability

This table compares IMAC and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
IMAC -75.40% -52.17% -34.51%
IMAC Competitors -5.53% -138.28% -0.40%
Valuation and Earnings

This table compares IMAC and its rivals revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
IMAC $15.22 million -$10.54 million -0.00
IMAC Competitors $20.41 billion $277.67 million -231.69

IMAC’s rivals have higher revenue and earnings than IMAC. IMAC is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Institutional and Insider Ownership

24.3% of IMAC shares are owned by institutional investors. Comparatively, 58.0% of shares of all “Healthcare Providers & Services” companies are owned by institutional investors. 10.0% of IMAC shares are owned by insiders. Comparatively, 15.2% of shares of all “Healthcare Providers & Services” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Risk and Volatility

IMAC has a beta of -0.88, suggesting that its share price is 188% less volatile than the S&P 500. Comparatively, IMAC’s rivals have a beta of 0.97, suggesting that their average share price is 3% less volatile than the S&P 500.

Summary

IMAC rivals beat IMAC on 7 of the 9 factors compared.

IMAC Company Profile

(Get Free Report)

IMAC logoIMAC Holdings, Inc. owns, manages, and subleases a chain of innovative medical advancements and care regeneration centers in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides physical therapy and spinal decompression, and chiropractic manipulation. The company owns or manages 15 outpatient medical clinics in Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Brentwood, Tennessee.

Receive News & Ratings for IMAC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAC and related companies with MarketBeat.com's FREE daily email newsletter.

You might be interested in:

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1SIFCO Industries (SIF) versus Its Competitors Critical Analysis04.710-08-2026
2Analyzing NEXON (NEXOF) & Its Competitors04.8409-08-2026
3Legrand (LGRVF) versus The Competition Critical Survey09.0410-08-2026
4Comparing Labrador Iron Ore Royalty (LIFZF) & Its Peers06.9610-08-2026
5Critical Analysis: Alternus Clean Energy (ALCED) & Its Rivals08.7609-08-2026
6Head to Head Contrast: Jewett-Cameron Trading (JCTC) and Its Competitors013.3710-08-2026
7Head to Head Comparison: Honda Motor (HMC) versus Its Peers010.0110-08-2026
8Analyzing Southern Banc (OTCMKTS:SRNN) & Grupo Financiero Inbursa (OTCMKTS:GPFOF)011.8810-08-2026
9Contrasting Intelligent Living Application Group (NASDAQ:ILAG) & Assa Abloy (OTCMKTS:ASAZY)08.2710-08-2026
10Analyzing Mettler-Toledo International (NYSE:MTD) and ImmunoPrecise Antibodies (OTCMKTS:IPATF)011.5410-08-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 3.69. Источник: www.themarketsdaily.com.